Entera Bio Ownership | Who Owns Entera Bio?
Entera Bio Ownership Summary
Entera Bio is owned by 21.27% institutional investors, 6.85% insiders, and 71.88% retail investors. Knoll capital management is the largest institutional shareholder, holding 12.73% of ENTX shares. WEALTHGATE Biotech Fund Inst is the top mutual fund, with 0.16% of its assets in Entera Bio shares.
ENTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Entera Bio | 21.27% | 6.85% | 71.88% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Knoll capital management | 5.88M | 12.73% | $6.47M |
| Renaissance | 473.44K | 1.02% | $525.52K |
| Parkman healthcare partners | 288.67K | 0.62% | $320.42K |
| Citadel advisors | 245.58K | 0.53% | $272.59K |
| Xtx topco | 131.62K | 0.28% | $146.10K |
| Schonfeld strategic advisors | 55.22K | 0.12% | $61.30K |
| Signature estate & investment advisors | 47.33K | 0.10% | $52.53K |
| Hightower advisors | 36.83K | 0.08% | $40.88K |
| Jane street group | 32.91K | 0.07% | $36.54K |
| Diadema partners lp | 23.26K | 0.05% | $25.82K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Knoll capital management | 5.88M | 3.59% | $6.47M |
| Parkman healthcare partners | 288.67K | 0.03% | $320.42K |
| Gem investment advisors | 19.14K | 0.02% | $21.24K |
| Diadema partners lp | 23.26K | 0.00% | $25.82K |
| Xtx topco | 131.62K | 0.00% | $146.10K |
| Persistent asset partners | 5.88K | 0.00% | $6.53K |
| Signature estate & investment advisors | 47.33K | 0.00% | $52.53K |
| Renaissance | 473.44K | 0.00% | $525.52K |
| Schonfeld strategic advisors | 55.22K | 0.00% | $61.30K |
| Gsa capital partners llp | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Renaissance | 473.44K | 0.00% | 365.44K |
| Citadel advisors | 245.58K | - | 205.35K |
| Xtx topco | 131.62K | 0.00% | 131.62K |
| Diadema partners lp | 23.26K | 0.00% | 23.26K |
| Hrt financial lp | 15.49K | - | 15.49K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Schonfeld strategic advisors | 55.22K | 0.00% | -541.36K |
| Marshall wace, llp | - | - | -195.78K |
| Northern trust | - | - | -146.85K |
| Perigon wealth management | - | - | -145.84K |
| Bessemer group | - | - | -140.84K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Diadema partners lp | 23.26K | 0.00% | 23.26K | $25.82K |
| Hrt financial lp | 15.49K | - | 15.49K | $17.00K |
| Jpmorgan chase | 7.15K | - | 7.15K | $7.15K |
| Persistent asset partners | 5.88K | 0.00% | 5.88K | $6.53K |
| Morgan stanley | 400.00 | - | 400.00 | $444.00 |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -2.00 |
| Caitong asset management | -20.00 |
| Royal bank of canada | -3.00K |
| Newedge advisors | -9.00K |
| Gsa capital partners llp | -11.89K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 28 | 7.69% | 10,728,883 | 36.30% | 21 | 7.83% | 15 | 15.38% | 6 | -14.29% |
| Mar 31, 2026 | 25 | 13.64% | 7,859,783 | -15.87% | 17 | 4.32% | 13 | 8.33% | 6 | 100.00% |
| Dec 31, 2025 | 10 | -54.55% | 327,954 | -96.43% | - | 0.18% | 5 | -28.57% | 1 | -87.50% |
| Sep 30, 2025 | 7 | -61.11% | 237,499 | -97.67% | - | 0.09% | 1 | -87.50% | 1 | -66.67% |
| Jun 30, 2025 | 19 | -5.00% | 10,211,002 | -0.11% | 23 | 4.24% | 8 | -20.00% | 4 | 100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| WEALTHGATE Biotech Fund Inst | 76.56K | 0.16% | 76.56K |
| Fidelity Nasdaq Composite Index | 29.91K | 0.06% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 09, 2026 | Germano Geno J | - | Buy | $26.00K |
| Mar 05, 2026 | Ellis Sean | - | Buy | $12.30K |
| Feb 10, 2026 | Taitel Haya | - | Buy | $11.10K |
| Feb 10, 2026 | Germano Geno J | - | Buy | $29.80K |
| Feb 09, 2026 | Ellis Sean | - | Buy | $22.32K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | - | - |
| 2026 Q1 | 5 | - |
| 2025 Q4 | 1 | - |
| 2025 Q3 | - | - |
ENTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools